IPT Autumn 2023 Front Cover.

Biotechshowcase.com

Contents for IPT Autumn 2023

As the nights get longer and the days get colder, and the wind picks up and the leaves change, the future of pharmatech is also continuing to change and evolve, as the increasing digitisation of lab processes and the integration of new technologies, all of which are currently taking the industry by storm, come together to create the ‘lab of the future’.

Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells

IPT talks to Oliver Rinner of Biognosys about Bruker’s recent majority investment in the business and how this, along with its own developments, will affect the future of proteomics research

With its potential to transform various industries and fields of research − including pharmaceuticals, preventive healthcare, agriculture and food safety − metabolomics is a rapidly growing field that has the potential to revolutionise our understanding of biological systems and disease mechanisms

Www.bgi.com

An exploration of the thoughts on the significance of generative AI within life sciences and pharma

What Pharma 4.0 looks like, the strategic role that a laboratory information management system plays and the presentation of a case study that underscores the power of a well-aligned digital strategy to catalyse innovation within organisations

Www.bioft-event.com

IPT talks to Robert Strzelecki at TenderHut group about the development of AI in the pharma industry and how its implementation will grow the sector

Www.mmc-series.org.uk

Www.biopharmagroupcdmo.com

Could the Cloud be the catalyst many pharma QC labs need in their race to the Lab of the Future?

As it grows more sophisticated, artificial intelligence will have transformative implications across virtually every industry on earth. One area in which this impact is already being felt is biotechnology, where it is playing a prominent role in everything from drug and vaccine development to providing global food security

Cphi.com/europe

Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide

While the drug-device combination product industry is always investing in technology that could better meet the needs of patients, governments and sponsors, the COVID-19 pandemic has accelerated the process, bringing in more outside investment and a broader range of organisations in active development

Elrig.org

Drug product optimisation, also known as reformulation, is a development step required by all drugs en route to market. This process takes a long time, carries a considerable cost and places significant emphasis on the predictive power of laboratory and preclinical assessments. What are some alternative pathways available to development teams?

What are some trends in the mRNA space surrounding the growing desire for speed-to-market, and what hurdles are impeding the achievement of this goal?

Bioeurope.com

'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs

Lab layouts, until the introduction of automation, had seen little change in decades. However, the increased usage of hardware and software lab automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments

IPT looks forward to some exciting and insightful events in the upcoming months

Interphex.com

Natoli.com